Tech Company Financing Transactions

Cardiac Dimensions Funding Round

Cardiac Dimensions, operating out of Kirkland, secured $15.2 million from Aperture Venture Partners, Life Sciences Partners and private investors.

Transaction Overview

Company Name
Announced On
3/11/2015
Transaction Type
Venture Equity
Amount
$15,200,000
Round
Undisclosed
Proceeds Purpose
The proceeds will be used to support the company's REDUCE FMR clinical trial. REDUCE FMR is the first blinded, randomized clinical trial of a percutaneous mitral repair device in patients with functional mitral regurgitation (FMR). Involving up to 20 leading hospitals in Europe and Australia, REDUCE FMR is being initiated with the objective to establish CARILLON as the gold standard therapy in the treatment of FMR. The proceeds will also be used to expand the company's research and development projects and its commercial operations.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
5540 Lake Washington Blvd. Northeast
Kirkland, WA 98033
USA
Email Address
Overview
The CARILLON Mitral Contour System is a groundbreaking, non-surgical device developed to treat functional mitral regurgitation.
Profile
Cardiac Dimensions LinkedIn Company Profile
Social Media
Cardiac Dimensions Company Twitter Account
Company News
Cardiac Dimensions News
Facebook
Cardiac Dimensions on Facebook
YouTube
Cardiac Dimensions on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Rick Wypych
  Rick Wypych LinkedIn Profile  Rick Wypych Twitter Account  Rick Wypych News  Rick Wypych on Facebook
Chief Medical Officer
Steven Goldberg
  Steven Goldberg LinkedIn Profile  Steven Goldberg Twitter Account  Steven Goldberg News  Steven Goldberg on Facebook
Vice President
Gretchen Gary
  Gretchen Gary LinkedIn Profile  Gretchen Gary Twitter Account  Gretchen Gary News  Gretchen Gary on Facebook
VP - Operations
Bob Calcote
  Bob Calcote LinkedIn Profile  Bob Calcote Twitter Account  Bob Calcote News  Bob Calcote on Facebook
VP - Regulatory Affairs
Matthew Stark
  Matthew Stark LinkedIn Profile  Matthew Stark Twitter Account  Matthew Stark News  Matthew Stark on Facebook
VP - Sales
Carmelo Mastrandrea
  Carmelo Mastrandrea LinkedIn Profile  Carmelo Mastrandrea Twitter Account  Carmelo Mastrandrea News  Carmelo Mastrandrea on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/11/2015: innRoad venture capital transaction
Next: 3/12/2015: Actelis Networks venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on funding rounds that are announced publicly. VC transactions reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary